Get our free email newsletter

FDA to Authorize Non-Prescription Hearing Aids

In a milestone development, the U.S. Food and Drug Administration (FDA) will soon authorize non-prescription hearing aids, potentially giving millions of hearing-impaired people access to affordable hearing devices.

In a Final Rule published in the Federal Register in mid-August, the FDA is establishing a regulatory category applicable to over-the-counter (OTC) hearing aids. The Final Rule also modifies existing labeling requirements and conditions for sale applicable to hearing aids to pave the way for certain models to be sold without a prescription from an authorized medical professional.

The FDA says it is in the process of finalizing general controls for OTC hearing aids consistent with the Federal Food, Drug, and Cosmetic Act as amended.

- Partner Content -

VSWR and its Effects on Power Amplifiers

Voltage Standing Wave Ratio results from an impedance mismatch between a source (an amplifier) and a load (test application). This mismatch can influence the performance of the source.

According to the FDA, hearing loss affects an estimated 30 million people in the U.S., impacting their ability to effectively communicate with others and compromising their overall health and safety. Yet, only about 20% of those affected by hearing impairments leverage current hearing aid technology to alleviate this disability, with the high cost of prescription hearing aids one of the main obstacles.

Read the FDA’s Final Rule on OTC hearing aids as published in the Federal Register.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, trending engineering news, and weekly recall alerts.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, trending engineering news, and weekly recall alerts.